Aurora B kinase targeting enhances BIM‐ and PUMA‐mediated apoptosis, which in turn prevents and counteracts EGFR inhibitor resistance in NSCLC (Tanaka et al. 2021). Here, EGFR is linked to non-small cell lung carcinoma.